FDA
approval
· 2018-03-23
FDA Approved: MESALAMINE — Original Application (Actavis Pharma, Inc.)
Summary
FDA approval of the original application (ANDA) for mesalamine, enabling its generic availability for the treatment of ulcerative colitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for MESALAMINE (MESALAMINE)